Treatment type 2 diabetes mellitus patients Grant US-10434147-B2 United States of America 08 Oct 2019
Treatment of type 2 diabetes mellitus patients Grant US-10159713-B2 United States of America 25 Dec 2018
Combination of an insulin and a GLP-1 agonist Grant US-10117909-B2 United States of America 06 Nov 2018
Pharmaceutical composition comprising a GLP-1-agonist and methionine Grant US-10028910-B2 United States of America 24 Jul 2018
Pharmaceutical composition for use in the treatment of a neurodegenerative disease Grant US-9987332-B2 United States of America 05 Jun 2018
Use of AVE0010 for the treatment of diabetes mellitus type 2 Grant US-9981013-B2 United States of America 29 May 2018
Insulin glargine/lixisenatide fixed ratio formulation Grant US-9950039-B2 United States of America 24 Apr 2018
Pharmaceutical combination for improving glycemic control as add-on therapy to basal… Grant US-9821032-B2 United States of America 21 Nov 2017
Pharmaceutical composition comprising a GLP-1 agonist and methionine Grant US-9707176-B2 United States of America 18 Jul 2017
TREATMENT OF TYPE 2 DIABETES MELLITUS PATIENTS Application WO-2016146812-A3 World Intellectual Property Organisation (WIPO) 03 Nov 2016